ArticleFrontiers in cardiovascular medicine2026
Usefulness of albumin-to-D-dimer ratio in predicting the long-term outcome after hospital discharge in patients with ST-elevation myocardial infarction: a retrospective cohort study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The Albumin-to-D-dimer ratio (ADR), a novel systemic inflammatory marker, has been linked to adverse outcomes in patients with cardiovascular disease. However, limited research has explored its prognostic value in ST-elevation myocardial infarction (STEMI) survivors following hospital discharge. This study aimed to evaluate the prognostic significance of ADR in hospital-discharged STEMI patients. Methods: In this retrospective study, we analyzed data from 2,675 STEMI patients admitted to our hospital between January 2014 and December 2021. Patients were stratified into two groups based on their natural logarithmic ADR (Ln ADR): a high Ln ADR group (≥3.998) and a low Ln ADR group (<3.998). Univariate and multivariate Cox regression analyses were performed to assess the association between Ln ADR levels and clinical outcomes, including all-cause mortality and new-onset stroke. Results: Over a mean follow-up period of 1,013 days (interquartile range: 466-1,449 days), the incidence of major adverse cardiovascular events (MACE) was significantly higher in the low Ln ADR group compared to the high Ln ADR group (20.87% vs. 12.33%, Conclusions: Reduced ADR levels were independently associated with increased long-term all-cause mortality and new-onset stroke in STEMI patients following hospital discharge. These findings suggest that ADR may serve as a valuable prognostic marker for risk stratification in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.